Pfizer has spent billions of dollars on acquisitions in the past few decades. Its biggest deals include Warner-Lambert, ...

Pfizer is exiting its HIV-focused joint venture, ViiV Healthcare, while reshaping its portfolio around other therapeutic ...

Jan 27 (Reuters) - The U.S. Centers for Medicare & Medicaid Services on Tuesday named a new group of branded drugs from major ...

Jan 27 (Reuters) - ‌The ​U.S. ‌Centers for ​Medicare & Medicaid ‍Services on ​Tuesday ​named a ⁠new group of branded drugs ...

Pfizer is acquiring Metsera, a clinical-stage biopharmaceutical company with a focus on medicines for obesity and cardiometabolic diseases, in a deal valued at up to $7.3 billion. “Pfizer said it ...

Pfizer's (NYSE:PFE) entry into the obesity treatment market through its $4.9B deal to acquire Metsera (NASDAQ:MTSR) is the latest indication that Big Pharma wants a piece of the weight loss drugs pie ...

Add Yahoo as a preferred source to see more of our stories on Google. President Donald Trump speaks in the Oval Office of the White House, Tuesday, Sept. 30, 2025, in Washington. (AP Photo/Alex ...

Pfizer is one of the world's largest pharmaceutical companies. Even after losing more than half of its value, it still has a ...

The Trump administration and Pfizer PFE announced an agreement on Sept. 30 that includes most-favored-nation pricing for Pfizer’s drugs in Medicaid programs, discounts for direct sales of Pfizer drugs ...

President Trump, during an Oval Office event Tuesday, called out Albert Bourla, the CEO of Pfizer, for overcharging Americans for prescription drugs. "The United States has just 4% of the world’s ...

Jan 27 (Reuters) - The U.S. Centers for Medicare & Medicaid Services on Tuesday named the 15 new drugs targeted for Medicare ...